D
Cidara Therapeutics, Inc. CDTX
$66.87 $2.744.27% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- 0.00 -- 302.00K
Total Other Revenue -- -- -- -- --
Total Revenue -- -- 0.00 -- 302.00K
Cost of Revenue 24.82M 24.60M 46.87M 12.43M 6.66M
Gross Profit -24.82M -24.60M -46.87M -12.43M -6.36M
SG&A Expenses 6.50M 6.18M 7.31M 4.97M 4.75M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -5.51M -- -- --
Total Operating Expenses 31.32M 25.27M 54.18M 17.39M 11.40M
Operating Income -31.32M -25.27M -54.18M -17.39M -11.10M
Income Before Tax -25.72M -23.48M -52.37M -15.54M -94.21M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -25.72M -23.48M -52.37M -15.54M -94.21M
Earnings from Discontinued Operations -- -- 62.00K -450.00K 3.00M
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -25.72M -23.48M -52.31M -15.99M -91.21M
EBIT -31.32M -25.27M -54.18M -17.39M -11.10M
EBITDA -31.29M -25.23M -54.14M -17.35M -11.06M
EPS Basic -1.65 -1.66 -5.38 -2.45 -19.99
Normalized Basic EPS -1.19 -1.04 -3.36 -1.49 -1.28
EPS Diluted -1.65 -1.66 -5.38 -2.45 -19.99
Normalized Diluted EPS -1.19 -1.04 -3.36 -1.49 -1.28
Average Basic Shares Outstanding 15.55M 14.18M 9.73M 6.53M 4.56M
Average Diluted Shares Outstanding 15.55M 14.18M 9.73M 6.53M 4.56M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --